Analyst Ratings for Editas Medicine (EDIT)
EDIT Rating Summary
EDIT Price Target Summary
- Highest: $15.00 (Evercore ISI)
- Lowest: $4.00 (Wells Fargo)
- Average: $7.10
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$7.10 (+163.9%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 40%
Avg. $ Target:
$7.10 (+163.9%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 40%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
8.00 (N/A) |
2.67 (2.69) |
0.75% | Details |
| 8/25/2025 | Evercore ISI » Updated 4/10/2026 |
Jonathan Miller | New Coverage | Outperform (N/A) |
15.00 (13.00) |
2.80 (2.69) |
-3.93% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
